Symptom reporting in over 1 million people: community detection of COVID-19 | medRxiv preprints (not peer reviewed)
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2021-03-20
Type
Journal Article
Author
Joshua Elliott
Author
Matthew Whitaker
Author
Barbara Bodinier
Author
Steven Riley
Author
Helen Ward
Author
Graham Cooke
Author
Ara Darzi
Author
Marc Chadeau-Hyam
Author
Paul Elliott
URL
https://www.medrxiv.org/content/10.1101/2021.02.10.21251480v1
Rights
© 2021, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/
Pages
2021.02.10.21251480
Publication
medRxiv | ICL
Date
12/02/2021
Extra
Publisher: Cold Spring Harbor Laboratory Press
DOI
10.1101/2021.02.10.21251480
Accessed
2021-03-20 15:21:22
Library Catalog
www.medrxiv.org
Language
en
Abstract
Control of the SARS-CoV-2 epidemic requires rapid identification and isolation of infected individuals and their contacts. Community testing in England (Pillar 2) by polymerase chain reaction (PCR) is reserved for those reporting at least one of four ‘classic’ COVID-19 symptoms (loss or change of sense of smell, loss or change of sense of taste, fever, new continuous cough).1 Detection of positive cases in the community might be improved by including additional symptoms and their combinations. We used data from the REal-time Assessment of Community Transmission-1 (REACT-1) study to investigate symptom profiles for PCR positivity at different ages. Among rounds 2–7 (June to December 2020), an age-stratified, variable selection approach stably selected chills (all ages), headache (5–17 years), appetite loss (18–54 and 55+ years) and muscle aches (18–54 years) as jointly and positively predictive of PCR positivity together with the classic four symptoms. Between round 7 (November to December 2020) and round 8 (January 2021) when new variant B.1.1.7 predominated, only loss or change of sense of smell (more predictive in round 7) and (borderline) new persistent cough (more predictive in round 8) differed between cases. At any level of PCR testing, triage based on the symptoms identified here would result in more cases detected than the current approach.
Short Title
Symptom reporting in over 1 million people